PMID: 16517820Mar 7, 2006Paper

Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours

The Veterinary Record
S MurphyK C Smith

Abstract

Between 1997 and 1999, 280 dogs with mast cell tumours were identified, of which 59 (21 per cent) had multiple tumours. Follow-up data for survival analysis were available for 145 dogs with single tumours and 50 dogs with multiple tumours. There was no significant difference between the survival times of the two groups; the survival rates after 12 and 24 months were 88 per cent and 83 per cent, respectively, for the dogs with single tumours, and 86 per cent at both intervals for the dogs with multiple tumours. Eight of the dogs with single tumours had lymph node metastases (stage II disease) and these dogs had a median survival time of 431 days, whereas the 50 dogs with multiple tumours (classified as stage III disease) and the dogs with single tumours (classified as stage I disease) had not reached their median survival times. Golden retrievers appeared to be predisposed to developing multiple tumours in the population studied, with an odds ratio of 3.8. This study found no evidence that dogs with multiple tumours had different survival times than those with single tumours, although there was evidence that the presence of lymph node metastasis generally carried a poorer prognosis.

Citations

Aug 7, 2009·Journal of Veterinary Internal Medicine·D StefanelloM Caniatti
Jun 6, 2013·ISRN Veterinary Science·Jane M Dobson
Apr 3, 2007·Journal of Comparative Pathology·S J NewmanB W Rohrbach
Jun 17, 2009·The Journal of Small Animal Practice·F TaylorJ Dobson
May 21, 2009·Veterinary and Comparative Oncology·J L TuohyW S Dernell
Nov 5, 2008·Veterinary Dermatology·Monika M WelleSilvia Rüfenacht
Jun 15, 2007·The Journal of Small Animal Practice·J M Dobson, T J Scase
Aug 14, 2012·Veterinary and Comparative Oncology·L BlackwoodD J Argyle
Sep 25, 2015·Canine Genetics and Epidemiology·Stephanie Jw ShoopDavid C Brodbelt
Dec 18, 2012·Veterinary and Comparative Oncology·J WarlandJ Dobson
Mar 16, 2013·Veterinary and Comparative Oncology·D BerlatoG A Maglennon
May 15, 2015·Veterinary and Comparative Oncology·Deanna R Worley
Jul 9, 2009·Acta Veterinaria Hungarica·Csaba JakabPéter Gálfi
May 3, 2016·The Journal of Small Animal Practice·J GrantD Lanore
Sep 1, 2017·Veterinary and Comparative Oncology·T ShawS M Firestone
Jul 27, 2018·Veterinary and Comparative Oncology·Laura MarconatoSilvia Sabattini
Mar 27, 2019·Veterinary and Comparative Oncology·Roberta Ferrari
Oct 28, 2019·Veterinary Medicine and Science·Vanessa S TamlinAnne E Peaston
Oct 27, 2017·Veterinary Medicine and Science·Juan Carlos Serra VarelaJessica Lawrence
Feb 21, 2019·Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·Jonathan R HughesRandi Drees
Mar 21, 2019·Veterinary and Comparative Oncology·Benjamin D ReynoldsBruce Gummow
Sep 16, 2020·Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·Katelyn C HluskoBrad M Matz
Dec 22, 2020·Topics in Companion Animal Medicine·Samanta Rios MeloJulia Maria Matera
Sep 27, 2021·Veterinary and Comparative Oncology·Csilla FejösJohannes Hirschberger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.